Learning CenterEducational ActivitiesView
Meeting

ACR Convergence

Date:

Nov 10–14, 2022

Location:

Philadelphia, PA
Coming Soon

Program Information

CME: TBA   MOC: TBA

ACR Convergence, the world’s premier rheumatology experience, will be held November 10–14 at the Pennsylvania Convention Center in Philadelphia, Pennsylvania. The meeting will be hosted in person with opportunities to view content virtually and on demand. Registration and housing details will be available in the spring. We look forward to seeing you in person in Philadelphia and virtually this fall!

About the ACR
Learn about the ACR’s Vision, Mission Statement, and values

Global Learning Objectives
Upon completion of this program, participants should be able to:

  • Identify recent developments in the diagnosis and management of patients with rheumatic diseases
  • Outline new technologies for the treatment of rheumatologic problems
  • Describe potential challenges in the delivery of care of patients with rheumatic diseases and specify possible solutions
  • Utilize new research data to improve the quality of care of patients with rheumatic diseases
  • Summarize recent rheumatology research findings

ACR Convergence 2021

On-demand content is available to On-Demand All Access Pass holders and ACR Convergence 2021 attendees through October 31, 2022.

Syllabi

Program syllabi will be available online during the meeting and for 12 months after the meeting to registered attendees. To access syllabi, login and go to My Educational Activities.

CME and MOC Information

Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The ACR designates this live activity for a maximum of (coming soon) AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

ACR Disclosure Statement
The ACR is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern. ACR Convergence is independently planned by the Annual Meeting Planning Committee under the direction of the ACR Committee on Education.

MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to (coming soon) Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and (coming soon) MOC points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC credit.

By completing this activity you provide the ACR permission to share completion data with the ACCME and the certifying board(s).

ABIM CME MOC Certified Part 2 ABP MOC

Faculty and Disclosures

ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

Nature of Financial Relationships
Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience all financial relationships with ineligible companies any financial or other relationship(s) with an ineligible company including, but not limited to:

  1. Advisor or review panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/research support
  6. Speaker/honoraria includes speaker's bureau, symposia, and expert witness
  7. Independent contractor
  8. Ownership interest
  9. Royalties
  10. Intellectual property/patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
  12. Other financial or material support

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

View ACR's ACCME disclosure practices

2022 disclosures coming soon

See 2021 disclosures in the ACR Convergence 2021 section below.

Corporate Support

The American College of Rheumatology thanks our corporate supporters and partners for their commitment to advancing rheumatology by supporting ACR and ARP programs and initiatives. See current supporters, guidelines, and benefits of supporting the ACR.

ACR Convergence 2021

CME: 143.00   MOC: 143.00

ACR Convergence 2021 showcased cutting-edge and timely topics in rheumatology, as well as the prevention, diagnosis, and treatment of rheumatic diseases and related comorbid conditions. The meeting offered hundreds of sessions to educate professionals in every segment of rheumatology: clinicians, researchers, academicians, practice managers, pediatric rheumatologists, fellows in training, advanced practice nurses, physician assistants, physical or occupational therapists.

About the ACR
Learn about the ACR’s Vision, Mission Statement, and values

Global Learning Objectives
Upon completion of this program, participants should be able to:

  • Identify recent developments in the diagnosis and management of patients with rheumatic diseases
  • Outline new technologies for the treatment of rheumatologic problems
  • Describe potential challenges in the delivery of care of patients with rheumatic diseases and specify possible solutions
  • Utilize new research data to improve the quality of care of patients with rheumatic diseases
  • Summarize recent rheumatology research findings

CME/MOC and Disclosure Information
See ACR Convergence 2021 continuing medical education (CME) and maintenance of certification (MOC) and disclosures.
View CME/MOC and Disclosure Information

The deadline to claim CME credit and MOC points for ACR Convergence 2021 is November 2, 2022 at 11:59 PM ET.

Quick Links

Contact Info / Inquiries

American College of Rheumatology
education@rheumatology.org
404-633-3777

Registration Support Center
If you need registration help, see information in the Support Center or contact us.

800-990-2446 (U.S. / Canada)
+1 415-979-2286
Monday - Friday, 9:00 AM - 9:00 PM ET
ACRsupport@cmrus.com

© 2022 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us